Vilin Bio Med Limited

₹54.55As of Sun 8 Nov 2026, 12:00 UTC
NSE:VILINBIOHealthcare
Country India
PE (Fwd) •••
TSR 3Y CAGR 21.32%
Div yield —
ROE 7.50%
Medical (Pharmaceuticals)
Beta (5Y) 0.68
PE TTM 43.29
TSR TTM 106.24%
Mkt cap ₹831.9M
ROIC 7.29%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹55
1.26%
(81.30%)
Hold 9|10|4|6|2
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.72
0.80
0.84
0.86
44.50%
44.98%
37.58%
30.68%
Revenue₹M
47.66
49.27
51.96
51.69
(0.15%)
1.32%
6.39%
6.70%
Peers (US$8.858M)
Cap (US$)
PE
14.80M
9.350x
7.067M
16.83x
Capital
TTM
5Y
10Y
Leveragex
0.941
0.078
0.077
EBIT/Intx
1.070
0.232
0.230
Own earn%
(115.98)
(60.21)
(56.54)
Sh yield%
30.62
39.05
35.57
Owners
Insiders/Inst%
11.51
22.75
Short interest%
1.77
SBC / revenue%
4.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
9–17
$1 testx
0.0
Incr. ROIC%
25